JP2005530696A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005530696A5 JP2005530696A5 JP2003570852A JP2003570852A JP2005530696A5 JP 2005530696 A5 JP2005530696 A5 JP 2005530696A5 JP 2003570852 A JP2003570852 A JP 2003570852A JP 2003570852 A JP2003570852 A JP 2003570852A JP 2005530696 A5 JP2005530696 A5 JP 2005530696A5
- Authority
- JP
- Japan
- Prior art keywords
- kit
- testing
- concentration
- less
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35965102P | 2002-02-27 | 2002-02-27 | |
| PCT/IB2003/001071 WO2003072106A2 (en) | 2002-02-27 | 2003-02-26 | Use of tyrosine kinase inhibitors for treating substance use disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005530696A JP2005530696A (ja) | 2005-10-13 |
| JP2005530696A5 true JP2005530696A5 (enExample) | 2006-03-09 |
Family
ID=27766119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003570852A Withdrawn JP2005530696A (ja) | 2002-02-27 | 2003-02-26 | 物質使用障害を治療するためのチロシンキナーゼ阻害剤の使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050203098A1 (enExample) |
| EP (1) | EP1490067B1 (enExample) |
| JP (1) | JP2005530696A (enExample) |
| AT (1) | ATE408407T1 (enExample) |
| AU (1) | AU2003209933A1 (enExample) |
| CA (1) | CA2477726A1 (enExample) |
| DE (1) | DE60323613D1 (enExample) |
| ES (1) | ES2314223T3 (enExample) |
| WO (1) | WO2003072106A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030034171A (ko) | 2001-07-06 | 2003-05-01 | 엔도 파마슈티걸즈, 인크. | 옥시모르폰 제어 방출 제형 |
| US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
| DK1404331T3 (da) | 2001-07-06 | 2008-01-28 | Penwest Pharmaceuticals Co | Sustained release-formuleringer af oxymorphon |
| ATE465731T1 (de) | 2003-10-23 | 2010-05-15 | Ab Science | 2-aminoaryloxazol-verbindungen als tyrosinkinase- hemmer |
| HRP20110709T1 (hr) | 2007-02-13 | 2011-11-30 | Ab Science | Postupak sinteze spojeva 2-aminotioazola kao inhibitora kinaza |
| CN105974131B (zh) * | 2016-06-16 | 2017-12-26 | 武汉大学 | c‑Kit作为药物成瘾治疗靶点的应用 |
| US20220079950A1 (en) * | 2018-12-31 | 2022-03-17 | The Regents Of The University Of California | Therapeutic combinations as antidotes for organophosphate exposure |
| CN112575073B (zh) * | 2019-09-30 | 2022-10-04 | 武汉大学 | c-Kit作为成瘾诊断及监测标志物的应用 |
| CN112569238A (zh) * | 2019-09-30 | 2021-03-30 | 武汉大学 | 伊马替尼及其衍生物与镇痛药联合用药或复方制剂在治疗疼痛中的应用 |
| US20240024325A1 (en) * | 2020-08-28 | 2024-01-25 | Emory University | Methods of Managing Cocaine or Other Drug Addictions |
| CN114573591B (zh) * | 2022-04-16 | 2023-04-25 | 成都施贝康生物医药科技有限公司 | 一种取代的吡咯并嘧啶化合物及其应用 |
| CN117461602B (zh) * | 2023-10-25 | 2024-10-25 | 六合熙诚(北京)信息科技有限公司 | 一种吗啡成瘾动物模型的构建方法 |
| WO2025264860A2 (en) | 2024-06-18 | 2025-12-26 | Yale University | Methods of treating post-covid airway disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW225528B (enExample) * | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag |
-
2003
- 2003-02-26 AT AT03743001T patent/ATE408407T1/de not_active IP Right Cessation
- 2003-02-26 EP EP03743001A patent/EP1490067B1/en not_active Expired - Lifetime
- 2003-02-26 WO PCT/IB2003/001071 patent/WO2003072106A2/en not_active Ceased
- 2003-02-26 DE DE60323613T patent/DE60323613D1/de not_active Expired - Fee Related
- 2003-02-26 CA CA002477726A patent/CA2477726A1/en not_active Abandoned
- 2003-02-26 ES ES03743001T patent/ES2314223T3/es not_active Expired - Lifetime
- 2003-02-26 JP JP2003570852A patent/JP2005530696A/ja not_active Withdrawn
- 2003-02-26 AU AU2003209933A patent/AU2003209933A1/en not_active Abandoned
- 2003-02-26 US US10/505,899 patent/US20050203098A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005515404A5 (enExample) | ||
| DE60215922D1 (de) | Filterelement, verfahren zu seiner herstellung und das element verwendender filter | |
| ATE541843T1 (de) | 2-acylamino-4-phenylthiazolderivate, ihre herstellung und anwendung als chemokin antagonisten | |
| DE502004011957D1 (de) | Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE602004024758D1 (de) | Polyimidzusammensetzungen mit Widerstand gegen Wassersorption, und Verfahren hierzu | |
| ATE556078T1 (de) | 2,4,6-phenylsubstituierte cyclische ketoenole | |
| DE60319694D1 (de) | Verpackungslaminat, verfahren zu seiner herstellung und aus dem verpackungslaminat hergestellter verpackungsbehälter | |
| ATE390278T1 (de) | Verpackungslaminat, verfahren zu seiner herstellung und aus dem verpackungslaminat hergestellter verpackungsbehälter | |
| DE60220245D1 (de) | Integriertes Widerstandselement, Phasenwechsel Speicherelement mit solchem Widerstandselement, und Verfahren zu seiner Herstellung | |
| JP2005515295A5 (enExample) | ||
| DE602005013692D1 (de) | Halbleiterbauelement und verfahren zu seiner herstellung | |
| ATE348609T1 (de) | Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
| ITMO20030289A1 (it) | Apparati, metodo e articolo. | |
| NO20070627L (no) | Silanoladditiv med lavt VOC-innhold og fremgangsmåter for fremstilling av det samme. | |
| ATE473738T1 (de) | 1-sulfonylindolderivate, verfahren zu ihrer herstellung und ihre verwendung als 5-ht6 liganden | |
| DE60216889D1 (de) | Vernetzbare Fluorelastomere | |
| EP1863769A4 (en) | HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS | |
| DE60239493D1 (de) | Halbleiterbauelement und verfahren zu seiner herstellung | |
| JP2005501564A5 (enExample) | ||
| IS8212A (is) | Nýjar 8-aza-bísýkló[3.2.1]oktanafleiður og notkunþeirra sem mónóamín-taugaboðefnaendurupptökuhindrar | |
| DE602006006597D1 (de) | Durchlüftetes nahrungsmittel und verfahren zu seiner herstellung | |
| NO20033998L (no) | Fremgangsmate for a bestemme resistivitetsindeksen, som en funksjon av vannmetning, til sten med kompleks porositet | |
| DE602004028584D1 (de) | Emulsionsförmiger haftklebstoff und verfahren zu seiner herstellung | |
| AU2003292182A1 (en) | Method for lowering both sequence variations and increase of base lines effects in diagnostic hybridisation assay, assay for performing such a method and probe for use in the assay | |
| JP2006505391A5 (enExample) |